In agreement with the existing literature, the present study also identified the PI3K/Akt (hsa04151) and MAPK (hsa04010) signaling pathways as key mechanisms for the potential therapeutic effect of CTFs on liver cancer. The gene discussed is AKT1; the disease is liver cancer.